Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-21

FDA Approved: ZALEPLON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for the generic sleep aid Zaleplon from Hikma Pharmaceuticals USA Inc., authorizing a modification to an already app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zaleplon (Zaleplon)

Snippet

SUPPL AP for ZALEPLON (ZALEPLON)